Radiosensitizer in advanced head and neck squamous cell carcinoma. Results of a randomized trial. Institute curie
β Scribed by S. Brunin; J.P. Batatnt; B. Asselain; C. Jaullery; N.A. Ghossetn
- Publisher
- Elsevier Science
- Year
- 1981
- Tongue
- English
- Weight
- 191 KB
- Volume
- 7
- Category
- Article
- ISSN
- 0360-3016
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## BACKGROUND. The authors previously have found that in patients with locally advanced squamous cell carcinoma of the head and neck (SCC-HN), alternating chemoradiotherapy (ALT) was superior to low-total-dose conventional radiotherapy alone. The purpose of this randomized trial was to compare the
Recently, attention has focused on the potential of oncogenes, tumour suppressor genes, and assessment of cell proliferation as biological response indicators in human cancer. In this study, immunocytochemical analysis was used to evaluate the usefulness of Ki67, epidermal growth factor receptor (EG